$HIMS 🚨 MASSIVE PEPTIDE NEWS 🚨 KEY QUOTES FROM THE WASHINGTON POST'S EXCLUSIVE REPORT: "The Trump administration is crafting plans that would allow the temporary sale of certain previously restricted peptides as federal health officials hammer out new regulations around the controversial products, according to two people familiar with the matter who spoke on the condition of anonymity to share private details." "Federal officials are seeking guardrails around the peptide policy, two people said." "Scott Brunner, the chief executive of the Alliance for Pharmacy Compounding, said his trade group has been seeking for the FDA to use what’s known as interim enforcement discretion — where the agency essentially acknowledges it will focus its enforcement resources on other matters — to pave the way to let state-licensed compounding pharmacies prepare the drugs for patients with a prescription." "He said he’s met twice with the FDA to lay out the approach his group would like to see federal regulators take, with certain conditions, including enhanced disclosures to patients, serious adverse event reporting and data collection on peptide use." "It was not immediately clear which peptides the administration is aiming to make temporarily available." "'We would encourage the HHS to use temporary enforcement discretion to allow access to these as soon as possible to help eliminate the gray and black market that currently exists,' said Lee Rosebush, the chairman of American Academy of Peptide Medicine."